Table 2.
Grade ≥2 Adverse Events Possibly, Probably, or Definitively Related to Therapy.
| Adverse Event | Grade 2 | Grade 3 | ||
|---|---|---|---|---|
| SABR, No. of Events | I-SABR, No. of Events | SABR, No. of Events | I-SABR, No. of Events | |
| Acute kidney injury | 1 | |||
| Adrenal insufficiency | 1 | |||
| Anorexia | 1 | |||
| Arthralgia | 2 | |||
| Blurred vision | 1 | |||
| Conjunctivitis | 1 | |||
| Diarrhea | 1 | |||
| Dyspnea | 1 | |||
| Fatigue | 1 | 7 | 2 | |
| Hyperthyroidism | 1 | |||
| Hypoxia | 1 | |||
| Hepatitis (acute) | 1 | |||
| Myalgia | 1 | |||
| Oral mucositis | 1 | |||
| Oral dysesthesia | 1 | |||
| Pneumonia (infectious) | 1 | |||
| Pneumonitis | 1 | 2 | ||
| Pruritus | 2 | |||
| Rash | 2 | 1 | ||
| Xeroophthalmia | 1 | |||
| Xerostomia | 1 | |||
Abbreviations: SABR, stereotactic ablative radiotherapy; I-SABR, immunotherapy + stereotactic ablative radiotherapy.
No grade 4–5 adverse events occurred.